PAHC FY 2018 Earnings Report — Phibro Animal Health Corporation Revenue & Financial Results | Market Cap Arena

Phibro Animal Health CorporationPAHC

FY 2018 Earnings

Reported August 27, 2018

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2018	Prior Q	FY 2017	QoQ Change	YoY Change
Revenue	$820M	—	$764M	—	7.3%
Op. Income	$99M	—	$98M	—	1.0%
Gross Margin	32.5%	—	32.5%	—	0.1pp
Net Margin	7.9%	—	8.5%	—	-0.5pp
EPS (Diluted)	$1.61	—	$1.61	—	0.0%
Free Cash Flow	$51M	—	$78M	—	-33.6%

Revenue Flow

Item	Amount
REVENUE	$820M
Cost of Revenue	$553M
GROSS PROFIT	$267M
R&D Expenses	$10M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$168M
Other Expenses	$0
Operating Expenses	$168M
Cost & Expenses	$721M
OPERATING INCOME	$99M
Interest Income	$2M
Interest Expense	$14M
Other Income/Expenses	-$11M
INCOME BEFORE TAX	$88M
Income Tax Expense	$23M
Net Income from Continuing Ops	$65M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$65M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$65M
D&A	$27M
EBIT	$101M
EBITDA	$129M
EPS	$2
EPS Diluted	$2

Income Statement

Item	Amount
REVENUE	$820M
Cost of Revenue	$553M
GROSS PROFIT	$267M
R&D Expenses	$10M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$168M
Other Expenses	$0
Operating Expenses	$168M
Cost & Expenses	$721M
OPERATING INCOME	$99M
Interest Income	$2M
Interest Expense	$14M
Other Income/Expenses	-$11M
INCOME BEFORE TAX	$88M
Income Tax Expense	$23M
Net Income from Continuing Ops	$65M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$65M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$65M
D&A	$27M
EBIT	$101M
EBITDA	$129M
EPS	$2
EPS Diluted	$2

Cash Flow Statement

Item	Amount
Net Income	$65M
Depreciation & Amortization	$27M
Stock-Based Compensation	$334.0K
Deferred Income Tax	$6M
Other Non-Cash Items	$6M
Change in Working Capital	-$34M
OPERATING CASH FLOW	$70M
Capital Expenditure	-$19M
Acquisitions (Net)	-$15M
Purchases of Investments	-$82M
Sales/Maturities of Investments	$32M
Other Investing Activities	-$1M
NET CASH FROM INVESTING	-$85M
Net Debt Issuance	-$1M
Common Stock Repurchased	$0
Common Dividends Paid	-$16M
Other Financing Activities	$0
NET CASH FROM FINANCING	-$12M
FREE CASH FLOW	$51M
Net Change in Cash	-$27M

Balance Sheet

Item	Amount
Cash & Equivalents	$29M
Short-Term Investments	$50M
Net Receivables	$136M
Inventory	$178M
Other Current Assets	$22M
TOTAL CURRENT ASSETS	$415M
PP&E (Net)	$130M
Goodwill	$27M
Intangible Assets	$52M
Long-Term Investments	$9M
Tax Assets	$15M
Other Non-Current Assets	$22M
TOTAL NON-CURRENT ASSETS	$256M
TOTAL ASSETS	$672M
Account Payables	$59M
Short-Term Debt	$13M
Deferred Revenue	$0
Other Current Liabilities	$55M
TOTAL CURRENT LIABILITIES	$143M
Long-Term Debt	$300M
Deferred Revenue NC	$0
Deferred Tax Liabilities	$10M
Other Non-Current Liabilities	$34M
TOTAL NON-CURRENT LIABILITIES	$344M
TOTAL LIABILITIES	$487M
Common Stock	$4.0K
Additional Paid-In Capital	$130M
Retained Earnings	$132M
Treasury Stock	$0
Accum. Other Comp. Income	-$76M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$185M
Minority Interest	$0
TOTAL EQUITY	$185M
TOTAL LIABILITIES & EQUITY	$672M
Total Debt	$312M
Net Debt	$283M